skip to Main Content

Humana January 2018 Pharmacy Policy Updates

Click here to view the Humana Pharmacy Policy Updates »

January 2018 Pharmacy Policy Updates

Policy Name Reviewed Date
ADHD Long Acting Stimulants 1/17/2018
Aggrenox® (aspirin/dipyridamole) 1/17/2018
Alecensa® (alectinib) 1/17/2018
Allergy Ophthalmics 1/17/2018
Aloxi® (palonosetron) 1/17/2018
Alphagan® P (brimonidine) 1/17/2018
AmBisome® (amphotericin B liposome) 1/17/2018
Aranesp® (darbepoetin alfa) 1/17/2018
Asthma Interleukin Inhibitors (Cinqair, Nucala, Fasenra) 1/17/2018
AzaSite® (azithromycin ophthalmic solution) 1/17/2018
Betaseron® [interferon beta-1b] 1/17/2018
Bowel Prep Agents 1/17/2018
Bowel Prep Agents 1/17/2018
Buprenorphine Containing Products 1/17/2018
Calquence® (acalabrutinib) 1/17/2018
Caprelsa® (vandetanib) 1/17/2018
Cervarix® (human papillomavirus bivalent vaccine) 1/17/2018
Cinvanti (aprepitant) 1/17/2018
Cometriq® (cabozantinib) 1/17/2018
Corticosteroid and Long Acting Beta Agonist Combination Inhalers 1/17/2018
Cosentyx® (secukinumab) 1/17/2018
Cosopt® (dorzolamide and timolol ophthalmic solution) 1/17/2018
Cresemba® (isavuconazonium sulfate) 1/17/2018
Dextroamphetamine/amphetamine extended release 1/17/2018
Dificid® (fidaxomicin) 1/17/2018
Dysport® (Botulinum Toxin) 1/17/2018
Eligard® (leuprolide acetate) 1/17/2018
Firmagon® (degarelix) 1/17/2018
Gardasil® (human papillomavirus vaccine) 1/17/2018
Gilenya® (fingolimod) 1/17/2018
Influenza Virus Vaccine 1/17/2018
Intranasal Rhinitis Agents 1/17/2018
Intuniv® (guanfacine extended-release tablets) 1/17/2018
Kapvay® (extended-release clonidine) 1/17/2018
Lemtrada® (alemtuzumab) 1/17/2018
Leuprolide acetate 1/17/2018
Lidoderm® (lidocaine 5% patch) 1/17/2018
Lonsurf® (trifluridine and tipiracil) 1/17/2018
Lupron® (leuprolide acetate) 1/17/2018
Mirvaso® (brimonidine topical gel) 1/17/2018
Myobloc® (Botulinum Toxin) 1/17/2018
Non-Sedating Antihistamines 1/17/2018
Noxafil® (posaconazole) 1/17/2018
Nulojix® (belatacept) 1/17/2018
Onivyde ® (liposomal irinotecan) 1/17/2018
Ophthalmic Antibiotics 1/17/2018
Ophthalmic Beta Blockers 1/17/2018
Ophthalmic Steroids 1/17/2018
Ophthalmic Steroids 1/17/2018
Portrazza™ (necitumumab) 1/17/2018
Portrazza™ (necitumumab) 1/17/2018
Qualaquin® (quinine sulfate) 1/17/2018
Quillivant XR® (methylphenidate hydrochloride) 1/17/2018
Radicava™ (edaravone) 1/17/2018
Ravicti® (glycerol phenylbutyrate) 1/17/2018
Rebif® (interferon beta-1a) 1/17/2018
Rhofade™ (oxymetazoline) cream 1/17/2018
Shingrix (zoster vaccine recombinant, adjuvanted) 1/17/2018
Sirturo® (bedaquiline) 1/17/2018
Sitavig® (acyclovir) 1/17/2018
Solaraze® (diclofenac) 1/17/2018
Soriatane® (acitretin) 1/17/2018
Strattera® (atomoxetine) 1/17/2018
Sublingual Allergen Extract 1/17/2018
Synagis® (palivizumab) 1/17/2018
Topical Metronidazole 1/17/2018
Topical Onychomycotic Agents (Jublia® and Kerydin®) 1/17/2018
Trelstar® (triptorelin pamoate) 1/17/2018
Triptans 1/17/2018
VFEND® (voriconazole) 1/17/2018
Vancomycin Oral Compound Solution 1/17/2018
Vectibix® (panitumumab) 1/17/2018
Vimizim® (elosulfase alfa) 1/17/2018
Viscosupplements (Durolane®, Euflexxa®, Gel-One®, Gelsyn-3™, GenVisc® 850, Hyalgan®, Hymovis®, Supartz™, Supartz FX™, Synvisc®, Synvisc-One®, Visco-3™) 1/17/2018
Votrient® (pazopanib) 1/17/2018
Vraylar™ (cariprazine) 1/17/2018
Vyvanse® (lisdexamfetamine dimesylate) 1/17/2018
Xeljanz® and Xeljanz XR® (tofacitinib) 1/17/2018
Xeomin® (Botulinum Toxin) 1/17/2018
Xuriden™ (uridine triacetate) 1/17/2018
Zaltrap® (ziv-aflibercept) 1/17/2018
Zinplava™ (bezlotoxumab) 1/17/2018
Zoladex® (goserelin) 1/17/2018
Zostavax® (zoster vaccine live) 1/17/2018
Zuplenz® (ondansetron oral soluble film) 1/17/2018
Prandial and Intermediate Acting Insulins 1/11/2018
Qtern® (dapagliflozin and saxagliptin) 1/4/2018


Click here to view the Humana Pharmacy Policy Updates »


Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Back To Top